{"product_id":"global-cell-and-gene-therapy-cdmo-supply-demand-and-key-producers-2023-2029","title":"Global Cell and Gene Therapy CDMO Supply, Demand and Key Producers, 2023-2029","description":"\u003cp\u003eGlobal Cell and Gene Therapy CDMO Supply, Demand and Key Producers, 2023-2029\u003cbr\u003e\nThe global Cell and Gene Therapy CDMO market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).\u003c\/p\u003e\n\n\u003cp\u003eThis report studies the global Cell and Gene Therapy CDMO demand, key companies, and key regions.\u003c\/p\u003e\n\n\u003cp\u003eThis report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy CDMO that contribute to its increasing demand across many markets.\u003c\/p\u003e\n\n\u003cp\u003eHighlights and key features of the study\u003c\/p\u003e\n\n\u003cp\u003eGlobal Cell and Gene Therapy CDMO total market, 2018-2029, (USD Million)\u003c\/p\u003e\n\n\u003cp\u003eGlobal Cell and Gene Therapy CDMO total market by region \u0026amp; country, CAGR, 2018-2029, (USD Million)\u003c\/p\u003e\n\n\u003cp\u003eU.S. VS China: Cell and Gene Therapy CDMO total market, key domestic companies and share, (USD Million)\u003c\/p\u003e\n\n\u003cp\u003eGlobal Cell and Gene Therapy CDMO revenue by player and market share 2018-2023, (USD Million)\u003c\/p\u003e\n\n\u003cp\u003eGlobal Cell and Gene Therapy CDMO total market by Type, CAGR, 2018-2029, (USD Million)\u003c\/p\u003e\n\n\u003cp\u003eGlobal Cell and Gene Therapy CDMO total market by Application, CAGR, 2018-2029, (USD Million).\u003c\/p\u003e\n\n\u003cp\u003eThis reports profiles major players in the global Cell and Gene Therapy CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Charles River Laboratories, Cytiva, Catalent Biologics, FUJIFILM Diosynth Biotechnologies, BioCentriq, RoslinCT, Thermo Scientific and Mesoblast, etc.\u003c\/p\u003e\n\n\u003cp\u003eThis report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.\u003c\/p\u003e\n\n\u003cp\u003eStakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell and Gene Therapy CDMO market.\u003c\/p\u003e\n\n\u003cp\u003eDetailed Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eEach section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Cell and Gene Therapy CDMO Market, By Region:\u003cbr\u003e\nUnited States\u003cbr\u003e\nChina\u003cbr\u003e\nEurope\u003cbr\u003e\nJapan\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nASEAN\u003cbr\u003e\nIndia\u003cbr\u003e\nRest of World\u003c\/p\u003e\n\n\u003cp\u003eGlobal Cell and Gene Therapy CDMO Market, Segmentation by Type\u003cbr\u003e\nClinical Trial Material CDMOs\u003cbr\u003e\nDevelopment and Manufacturing CDMOs\u003cbr\u003e\nOther\u003c\/p\u003e\n\n\u003cp\u003eGlobal Cell and Gene Therapy CDMO Market, Segmentation by Application\u003cbr\u003e\nPharmaceutical Company\u003cbr\u003e\nBiotechnology Company\u003cbr\u003e\nOther\u003c\/p\u003e\n\n\u003cp\u003eCompanies Profiled:\u003cbr\u003e\nLonza\u003cbr\u003e\nCharles River Laboratories\u003cbr\u003e\nCytiva\u003cbr\u003e\nCatalent Biologics\u003cbr\u003e\nFUJIFILM Diosynth Biotechnologies\u003cbr\u003e\nBioCentriq\u003cbr\u003e\nRoslinCT\u003cbr\u003e\nThermo Scientific\u003cbr\u003e\nMesoblast\u003cbr\u003e\nCellularity\u003cbr\u003e\nBluebird Bio\u003cbr\u003e\nEditas Medicine\u003cbr\u003e\nAndelyn Biosciences\u003cbr\u003e\nWuxi Advanced Therapies\u003cbr\u003e\nAGC Biologics\u003cbr\u003e\nPfizer CentreOne\u003cbr\u003e\nAlmac Group\u003cbr\u003e\nPCI Pharma Services\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered\u003c\/p\u003e\n\n\u003cp\u003e1. How big is the global Cell and Gene Therapy CDMO market?\u003c\/p\u003e\n\n\u003cp\u003e2. What is the demand of the global Cell and Gene Therapy CDMO market?\u003c\/p\u003e\n\n\u003cp\u003e3. What is the year over year growth of the global Cell and Gene Therapy CDMO market?\u003c\/p\u003e\n\n\u003cp\u003e4. What is the total value of the global Cell and Gene Therapy CDMO market?\u003c\/p\u003e\n\n\u003cp\u003e5. Who are the major players in the global Cell and Gene Therapy CDMO market?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"October, 2023 \/ 122 Pages \/ MCW16232972","offer_id":47648503333170,"sku":null,"price":5376.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-cell-and-gene-therapy-cdmo-supply-demand-and-key-producers-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}